Mon, 19 Nov 2018 12:00:00 EST Achieving the Quadruple Aim by Reducing Burnout Condition: Burnout, Professional Intervention: Behavioral: Compassion Curriculum Sponsor: Providence Health & Services Completed
Mon, 19 Nov 2018 12:00:00 EST An Investigational Study of Experimental Medication Supaglutide Injection Given With the Placebo in Healthy Participants Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Supaglutide injection; Drug: Placebo Sponsors: Shanghai Innogen Pharmaceutical Technology Co.,Ltd; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Tigermed Consulting Co., Ltd; Mosim Co., Ltd.; Linking Truth Technology Co., Ltd.; Medidata Solutions Not yet recruiting
Mon, 19 Nov 2018 12:00:00 EST Effects of Non-alcoholic Beer in Patients With Type 2 Diabetes Condition: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: Water; Dietary Supplement: Non-alcoholic beer Sponsors: Universidade do Porto; CINTESIS - Centre for Health Technology and Services Research; NOVA Medical School, NOVA University of Lisbon Recruiting
Mon, 19 Nov 2018 12:00:00 EST PDD in Type 2 Diabetes w/wo Diastolic Dysfunction Conditions: Diabetes Mellitus, Type 2; Diastolic Dysfunction Interventions: Drug: Nesiritide Injection; Drug: LCZ 696; Drug: Placebos Sponsor: Mayo Clinic Recruiting
Mon, 19 Nov 2018 12:00:00 EST Project to Improve Communication About Serious Illness - Pilot Study Conditions: Malignant Neoplasm; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Disease Chronic; Congestive Heart Failure; Liver Failures, Chronic; Renal Insufficiency, Chronic; Dementia; Diabetes Complications; Peripheral Vascular Disease; Frail Elderly Intervention: Behavioral: Jumpstart Intervention Sponsor: University of Washington Recruiting
Mon, 19 Nov 2018 12:00:00 EST The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine Conditions: Vitamin B1 Deficiency; Thiamine Deficiency Interventions: Drug: Trimethoprim; Drug: Metformin; Dietary Supplement: Vitamin B1 Sponsors: University of California, San Francisco; Tufts University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of California, Davis Not yet recruiting
Mon, 19 Nov 2018 12:00:00 EST The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies Conditions: Systemic Lupus Erythematosus; Pregnancy Complications Intervention: Sponsors: McGill University Health Center; Duke University; University of California, Los Angeles; Dalhousie University; Hanyang University; Hospital for Special Surgery, New York; Johns Hopkins University; Monash University; New York University; Oklahoma Medical Research Foundation; University of North Carolina; Temple University; University of Alabama at Birmingham; University of Birmingham; University of Calgary; University of California; University of Copenhagen; University of Manitoba; University of Michigan; University of Toronto; New York University School of Medicine; University of British Columbia; National Institute of Medical Science & Nutrition; Laval University; University Health Network, Toronto Recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Mon, 19 Nov 2018 12:54:00 -0500 FDA approves new drug to treat travelers’ diarrhea FDA approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.
Fri, 16 Nov 2018 11:11:00 -0500 FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL). This is the first FDA approval for treatment of newly diagnosed PTCL, and the agency used a new review program to complete the approval more quickly.
